BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38512764)

  • 1. N6-methyladenosine reader hnRNPA2B1 recognizes and stabilizes NEAT1 to confer chemoresistance in gastric cancer.
    Wang J; Zhang J; Liu H; Meng L; Gao X; Zhao Y; Wang C; Gao X; Fan A; Cao T; Fan D; Zhao X; Lu Y
    Cancer Commun (Lond); 2024 Apr; 44(4):469-490. PubMed ID: 38512764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m
    Liu H; Li D; Sun L; Qin H; Fan A; Meng L; Graves-Deal R; Glass SE; Franklin JL; Liu Q; Wang J; Yeatman TJ; Guo H; Zong H; Jin S; Chen Z; Deng T; Fang Y; Li C; Karijolich J; Patton JG; Wang X; Nie Y; Fan D; Coffey RJ; Zhao X; Lu Y
    Mol Cancer; 2022 Mar; 21(1):74. PubMed ID: 35279145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HNRNPA2B1 inhibited SFRP2 and activated Wnt-β/catenin via m6A-mediated miR-106b-5p processing to aggravate stemness in lung adenocarcinoma.
    Rong L; Xu Y; Zhang K; Jin L; Liu X
    Pathol Res Pract; 2022 May; 233():153794. PubMed ID: 35364458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness.
    Shin VY; Chen J; Cheuk IW; Siu MT; Ho CW; Wang X; Jin H; Kwong A
    Cell Death Dis; 2019 Mar; 10(4):270. PubMed ID: 30894512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA LINC00942 promotes chemoresistance in gastric cancer by suppressing MSI2 degradation to enhance c-Myc mRNA stability.
    Zhu Y; Zhou B; Hu X; Ying S; Zhou Q; Xu W; Feng L; Hou T; Wang X; Zhu L; Jin H
    Clin Transl Med; 2022 Jan; 12(1):e703. PubMed ID: 35073459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-methyladenosine modification of CENPF mRNA facilitates gastric cancer metastasis via regulating FAK nuclear export.
    Xu P; Yang J; Chen Z; Zhang X; Xia Y; Wang S; Wang W; Xu Z
    Cancer Commun (Lond); 2023 Jun; 43(6):685-705. PubMed ID: 37256823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HNRNPA2B1-mediated m
    Li K; Gong Q; Xiang XD; Guo G; Liu J; Zhao L; Li J; Chen N; Li H; Zhang LJ; Zhou CY; Wang ZY; Zhuang L
    J Transl Med; 2023 Jun; 21(1):382. PubMed ID: 37308993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA miR503HG, a prognostic indicator, inhibits tumor metastasis by regulating the HNRNPA2B1/NF-κB pathway in hepatocellular carcinoma.
    Wang H; Liang L; Dong Q; Huan L; He J; Li B; Yang C; Jin H; Wei L; Yu C; Zhao F; Li J; Yao M; Qin W; Qin L; He X
    Theranostics; 2018; 8(10):2814-2829. PubMed ID: 29774077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer.
    Jia Y; Yan Q; Zheng Y; Li L; Zhang B; Chang Z; Wang Z; Tang H; Qin Y; Guan XY
    J Exp Clin Cancer Res; 2022 Sep; 41(1):287. PubMed ID: 36171622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALKBH5 promotes invasion and metastasis of gastric cancer by decreasing methylation of the lncRNA NEAT1.
    Zhang J; Guo S; Piao HY; Wang Y; Wu Y; Meng XY; Yang D; Zheng ZC; Zhao Y
    J Physiol Biochem; 2019 Aug; 75(3):379-389. PubMed ID: 31290116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA SNHG8 promotes chemoresistance in gastric cancer via binding with hnRNPA1 and stabilizing TROY expression.
    Zhu W; Tan L; Ma T; Yin Z; Gao J
    Dig Liver Dis; 2022 Nov; 54(11):1573-1582. PubMed ID: 35354542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
    Ma X; Wang B; Wang X; Luo Y; Fan W
    PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
    Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
    J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
    [